Where to buy eflornithine tablets

Eflornithine tablets (eflornithine) is a targeted ornithine decarboxylase (ODC) inhibitor, mainly used for the maintenance treatment of patients with rare high-risk neuroblastoma (HRNB). Its mechanism is to inhibit the activity of ODC enzyme and block the polyamine synthesis pathway that cancer cells depend on, thereby inhibiting cell proliferation and tumor recurrence. Especially for those patients who have achieved partial remission after receiving multimodal treatments (such as chemotherapy, stem cell transplantation, radiotherapy, and anti-GD2 immunotherapy), eflornithine tablets are regarded as an important maintenance treatment to reduce the risk of recurrence. The drug has strong targeting and relatively mild side effects, and is suitable for long-term use in children and adults. Therefore, it has attracted widespread attention in the field of international pediatric cancer treatment in recent years.

At present, eflornithine tablets have not been officially launched in mainland China, so they cannot be purchased through regular channels in domestic hospitals and pharmacies. Because it has not been approved by the State Food and Drug Administration, its price, medical insurance reimbursement policy, clinical promotion and other information are all in the blank stage. However, in the U.S. and European markets, eflornithine tablets have obtained orphan drug status and are produced by exclusive pharmaceutical companies. The main specifications are 192 mg × 100 tablets. According to public channels, the price per box is about US$10,000, which is a typical high-priced rare disease drug. At present, there are no generic versions of drugs on the market. The market is mainly occupied by original drugs, and the supply channels are also relatively concentrated.

For Chinese patients, if they need to use eflornithine tablets clinically, they can obtain it through legal overseas drug purchase platforms, international medical cooperation institutions, or by participating in overseas clinical trials. Since this drug is expensive and requires long-term oral maintenance, it is recommended that patients fully communicate with their doctors before starting to use it, confirm its clinical indications and efficacy expectations, and make long-term economic plans.

Reference materials:https://www.drugs.com/mtm/eflornithine.html